GlassScriptPhysician profile
Jasmine Leong
NPI 1083627798
$1,619.67
in general payments reported to CMS, 2019-2025
20 companies · $24.40 in 2025
The $24.40 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,237 · 2020: $161 · 2021: $12.20 · 2022: $185 · 2025: $24.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $517.24 | 2019-2020 | |
| Glaxosmithkline, LLC. | $186.21 | 2019 | |
| Pfizer INC. | $144.12 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $143.76 | 2022 | |
| Novo Nordisk INC | $92.34 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $75.68 | 2019-2020 | |
| Abbott Laboratories | $57.75 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.33 | 2019 | |
| Eisai INC. | $51.44 | 2020 | |
| Merck Sharp & Dohme LLC | $43.45 | 2019 | |
| Amarin Pharma, INC. | $36.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $34.55 | 2019 | |
| Sanofi-Aventis U.S. LLC | $32.30 | 2019 | |
| Allergan, INC. | $31.55 | 2019 | |
| Alexion Pharmaceuticals, INC. | $26.74 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.61 | 2019 | |
| Sanofi Pasteur INC. | $20.47 | 2020 | |
| Hologic Sales and Service, LLC | $17.85 | 2022 | |
| Mannkind Corporation | $15.87 | 2019 | |
| Bard Peripheral Vascular, INC. | $12.20 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Leong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.